| For: | Ferolla SM, Armiliato GNA, Couto CA, Ferrari TCA. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol 2015; 7(3): 559-565 [PMID: 25848479 DOI: 10.4254/wjh.v7.i3.559] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/559.htm |
| Number | Citing Articles |
| 1 |
Xuyun He, Guang Ji, Wei Jia, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. International Journal of Molecular Sciences 2016; 17(3) doi: 10.3390/ijms17030300
|
| 2 |
Boyeon Kim, Bukyung Kim. Gut microbiota and nonalcoholic fatty liver disease . Kosin Medical Journal 2023; 38(3) doi: 10.7180/kmj.23.138
|
| 3 |
Laraib Shoukat, Sadia Javed, Muhammad Afzaal, Naheed Akhter, Yasir Abbas Shah. Starch-based encapsulation to enhance probiotic viability in simulated digestion conditions. International Journal of Biological Macromolecules 2024; 283 doi: 10.1016/j.ijbiomac.2024.137606
|
| 4 |
Y.-H. Ho, Y.-T. Huang, Y.-C. Lu, S.-Y. Lee, M.-F. Tsai, S.-P. Hung, Ting-Yuan Hsu. Effects of gender and age on immune responses of human peripheral blood mononuclear cells to probiotics: A large scale pilot study. The Journal of nutrition, health and aging 2017; 21(5) doi: 10.1007/s12603-016-0818-7
|
| 5 |
Makoto Usami, Makoto Miyoshi, Hayato Yamashita. Gut microbiota and host metabolism in liver cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11597-11608 doi: 10.3748/wjg.v21.i41.11597
|
| 6 |
Alessandro Federico, Marcello Dallio, Justyna Godos, Carmela Loguercio, Federico Salomone. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. Translational Research 2016; 167(1) doi: 10.1016/j.trsl.2015.08.002
|
| 7 |
Guido Carpino, Maria Del Ben, Daniele Pastori, Roberto Carnevale, Francesco Baratta, Diletta Overi, Heather Francis, Vincenzo Cardinale, Paolo Onori, Samira Safarikia, Vittoria Cammisotto, Domenico Alvaro, Gianluca Svegliati‐Baroni, Francesco Angelico, Eugenio Gaudio, Francesco Violi. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. Hepatology 2020; 72(2) doi: 10.1002/hep.31056
|
| 8 |
Mustafa Tahsin Yilmaz, Osman Taylan, Canan Yagmur Karakas, Enes Dertli. An alternative way to encapsulate probiotics within electrospun alginate nanofibers as monitored under simulated gastrointestinal conditions and in kefir. Carbohydrate Polymers 2020; 244 doi: 10.1016/j.carbpol.2020.116447
|
| 9 |
Yan Yan, Chunyan Liu, Shimin Zhao, Xinxu Wang, Jinling Wang, Heping Zhang, Yuzhen Wang, Guofen Zhao. Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease. AMB Express 2020; 10(1) doi: 10.1186/s13568-020-01038-y
|
| 10 |
WeiZhou Wang, YunTao Tang, ZiQian Wan, ZhiQuan Zhang, ZhouHang Zheng, HuiLong Liu, QiPeng Shu, ShangZe Li. Gut microbiota modulates nonalcoholic fatty liver disease (NAFLD) progression via regulation of gluconeogenesis: mechanisms and translational research. Pharmacological Research 2026; 233 doi: 10.1016/j.phrs.2026.108444
|
| 11 |
Amin Salehi-Abargouei, Reza Ghiasvand, Mitra Hariri. Prebiotics, Prosynbiotics and Synbiotics: Can They Reduce Plasma Oxidative Stress Parameters? A Systematic Review. Probiotics and Antimicrobial Proteins 2017; 9(1) doi: 10.1007/s12602-016-9248-4
|
| 12 |
Mariana Machado, Helena Cortez-Pinto. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. International Journal of Molecular Sciences 2016; 17(4) doi: 10.3390/ijms17040481
|
| 13 |
Yupei Zhang, Kairui Tang, Yuanjun Deng, Runsen Chen, Shu Liang, Huijun Xie, Yifang He, Yanning Chen, Qinhe Yang. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. Biomedicine & Pharmacotherapy 2018; 102 doi: 10.1016/j.biopha.2018.03.158
|
| 14 |
Chunli Ma, Yulong Bao, Saqirina Hereid, Haixia Zhang, Xiaohong Bai, Qilimuge Bai, Linyun Zhao, Xin Zhang, Hua Lian, Lili Dai, Xilinqiqige Bao, Liang Bao. Mechanistic Elucidation of Tricholoma mongolicum Polysaccharides in Treating MAFLD via Regulation of the Gut Microbiota–Metabolite–Ferroptosis Axis: A Multi-Omics Perspective. Journal of Agricultural and Food Chemistry 2025; 73(27) doi: 10.1021/acs.jafc.5c05877
|
| 15 |
M.-Y. Park, S.J. Kim, E.K. Ko, S.-H. Ahn, H. Seo, M.-K. Sung. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice. Journal of Applied Microbiology 2016; 121(3) doi: 10.1111/jam.13158
|
| 16 |
Mingfei Yao, Jiong Wu, Bo Li, Hang Xiao, David Julian McClements, Lanjuan Li. Microencapsulation of Lactobacillus salivarious Li01 for enhanced storage viability and targeted delivery to gut microbiota. Food Hydrocolloids 2017; 72 doi: 10.1016/j.foodhyd.2017.05.033
|
| 17 |
Guanhong Xue, Zhijie Zheng, Xiaoben Liang, Yonghui Zheng, Haichong Wu, Yunhe Fu. Uterine Tissue Metabonomics Combined with 16S rRNA Gene Sequencing To Analyze the Changes of Gut Microbiota in Mice with Endometritis and the Intervention Effect of Tau Interferon. Microbiology Spectrum 2023; 11(3) doi: 10.1128/spectrum.00409-23
|
| 18 |
Niama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, Jun Yu. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer. Cancer Letters 2019; 459 doi: 10.1016/j.canlet.2019.114425
|
| 19 |
Bashar Aqel, John K. DiBaise. Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Nutrition in Clinical Practice 2015; 30(6) doi: 10.1177/0884533615605811
|
| 20 |
Zahra Shariaty, Gholam Reza Mahmoodi Shan, Mehran Farajollahi, Monireh Amerian, Naser Behnam Pour. The effects of probiotic supplement on hemoglobin in chronic renal failure patients under hemodialysis: A randomized clinical trial. Journal of Research in Medical Sciences 2017; 22(1) doi: 10.4103/jrms.JRMS_614_16
|
| 21 |
Tianyu Wang, Dawei Wang, Yinghui Ding, He Xu, Yue Sun, Jumin Hou, Yanrong Zhang. Targeting Non-Alcoholic Fatty Liver Disease with Hawthorn Ethanol Extract (HEE): A Comprehensive Examination of Hepatic Lipid Reduction and Gut Microbiota Modulation. Nutrients 2024; 16(9) doi: 10.3390/nu16091335
|
| 22 |
David Avelar-Rodríguez, Rubén Peña-Vélez, Jelena Popov, Lee Hill, Paul MacDaragh Ryan. Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review. Revista Española de Enfermedades Digestivas 2022; doi: 10.17235/reed.2022.8796/2022
|
| 23 |
Juanjuan Zhu, Mingyu Zhou, Xueke Zhao, Mao Mu, Mingliang Cheng. Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver diseaseviaIL-22-mediated JAK1/STAT3/BAX signaling. Food & Function 2018; 9(12) doi: 10.1039/C8FO01227J
|
| 24 |
Haiming Hu, Aizhen Lin, Mingwang Kong, Xiaowei Yao, Mingzhu Yin, Hui Xia, Jun Ma, Hongtao Liu. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. Journal of Gastroenterology 2020; 55(2) doi: 10.1007/s00535-019-01649-8
|
| 25 |
Paulraj Kanmani, Julio Villena, Soo‐kyoung Lim, Eun‐Ji Song, Young‐Do Nam, Hojun Kim. Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl‐Hydrocarbon Receptors Pathway in Non‐Alcoholic Steatohepatitis Mice. Molecular Nutrition & Food Research 2024; 68(14) doi: 10.1002/mnfr.202400227
|
| 26 |
Yi‐Ming Chen, Chen‐Chung Liao, Yen‐Chun Huang, Ming‐Yi Chen, Chi‐Chang Huang, Wen‐Chyuan Chen, Yen‐Shuo Chiu. Proteome and microbiota analysis highlight Lactobacillus plantarum TWK10 supplementation improves energy metabolism and exercise performance in mice. Food Science & Nutrition 2020; 8(7) doi: 10.1002/fsn3.1635
|
| 27 |
Jia Wang, Yanfei Hao, Xiao Jin, Xiaoyue Li, Yi Liu, Li Zhang, Jing Wang, Mingxin Hu, Shimin Wang. Health Effects of Probiotics on Nonalcoholic Fatty Liver in the Life Cycle Based on Data Analysis. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/2123162
|
| 28 |
Zhen-Shu Liu, Pei-Lin Li, Yu-We Ku, Po-Wen Chen. Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice. Microorganisms 2022; 10(11) doi: 10.3390/microorganisms10112215
|
| 29 |
Fatemeh Famouri, Zainab Shariat, Mahin Hashemipour, Mojtaba Keikha, Roya Kelishadi. Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(3) doi: 10.1097/MPG.0000000000001422
|
| 30 |
Leila Javadi, Mostafa Ghavami, Manouchehr Khoshbaten, Abdolrasoul Safaiyan, Abolfazl Barzegari, Bahram Pourghassem Gargari. The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial. Iranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.46017
|
| 31 |
Huikuan Chu, Brandon Williams, Bernd Schnabl. Gut microbiota, fatty liver disease, and hepatocellular carcinoma. Liver Research 2018; 2(1) doi: 10.1016/j.livres.2017.11.005
|
| 32 |
Diletta Overi, Guido Carpino, Antonio Franchitto, Paolo Onori, Eugenio Gaudio. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis. Cells 2020; 9(3) doi: 10.3390/cells9030590
|
| 33 |
En-Hua Mei, Chao Yao, Yi-Nan Chen, Shun-Xue Nan, Sheng-Cai Qi. Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease. World Journal of Hepatology 2024; 16(5): 688-702 doi: 10.4254/wjh.v16.i5.688
|
| 34 |
|
| 35 |
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology 2016; 13(7) doi: 10.1038/nrgastro.2016.85
|
| 36 |
厚法 周. Research Progress of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease. Advances in Clinical Medicine 2022; 12(08) doi: 10.12677/ACM.2022.1281047
|
| 37 |
Richard LJ Day, Ashton J Harper, Rachel M Woods, Owen G Davies, Liam M Heaney. Probiotics: Current Landscape and Future Horizons. Future Science OA 2019; 5(4) doi: 10.4155/fsoa-2019-0004
|
| 38 |
Zahra Safari, Philippe Gérard. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cellular and Molecular Life Sciences 2019; 76(8) doi: 10.1007/s00018-019-03011-w
|
| 39 |
Qian Hu, Ying Liu, Youmei Fei, Jingping Zhang, Shao Yin, Hui Zou, Fengya Zhu. Efficacy of probiotic, prebiotic, and synbiotics supplements in individuals with anemia: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03562-8
|
| 40 |
Tanya Ralli, Zoya Saifi, Neha Tyagi, Arya Vidyadhari, Vidhu Aeri, Kanchan Kohli. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease. Critical Reviews in Microbiology 2023; 49(6) doi: 10.1080/1040841X.2022.2142091
|
| 41 |
Giorgia Spaggiari, Giulia Brigante, Sara De Vincentis, Umberto Cattini, Laura Roli, Maria Cristina De Santis, Enrica Baraldi, Simonetta Tagliavini, Manuela Varani, Tommaso Trenti, Vincenzo Rochira, Manuela Simoni, Daniele Santi. Probiotics Ingestion Does Not Directly Affect Thyroid Hormonal Parameters in Hypothyroid Patients on Levothyroxine Treatment. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00316
|
| 42 |
Ruiting Han, Junli Ma, Houkai Li. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Frontiers of Medicine 2018; 12(6) doi: 10.1007/s11684-018-0645-9
|